Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127447412 | 12744741 | 2 | F | 20140319 | 20160914 | 20160915 | 20160916 | EXP | FR-BAXTER-2016BAX046222 | BAXTER | 10.78 | YR | F | Y | 27.80000 | KG | 20160916 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127447412 | 12744741 | 1 | PS | UROMITEXAN 5 G/50 ML, SOLUTION INJECTABLE POUR PERFUSION EN FLACON | MESNA | 1 | Intravenous (not otherwise specified) | ONCE IN ONE SINGLE INTAKE | D | 19884 | 3700 | MG | SOLUTION FOR INJECTION | ||||||
| 127447412 | 12744741 | 2 | SS | Ifosfamide EG | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | INFUSION, FIRST COURSE, WITHDRAWN AFTER DAY 2 TREATMENT DUE TO THE EVENT | Y | 0 | 3 | MG/M**2 | QD | ||||||
| 127447412 | 12744741 | 3 | SS | ETOPOPHOS | ETOPOSIDE PHOSPHATE | 1 | Unknown | FIRST COURSE | 0 | /cycle | |||||||||
| 127447412 | 12744741 | 4 | C | Zophren | ONDANSETRON | 1 | Unknown | 0 | |||||||||||
| 127447412 | 12744741 | 5 | C | Eludril | CHLORHEXIDINE GLUCONATECHLOROBUTANOL | 1 | Unknown | 0 | |||||||||||
| 127447412 | 12744741 | 6 | C | Diffu K | POTASSIUM CHLORIDE | 1 | Unknown | 0 | |||||||||||
| 127447412 | 12744741 | 7 | C | Cacit | CALCIUMVITAMIN D | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127447412 | 12744741 | 1 | Nephroprotective therapy |
| 127447412 | 12744741 | 2 | Osteosarcoma |
| 127447412 | 12744741 | 3 | Osteosarcoma |
| 127447412 | 12744741 | 4 | Product used for unknown indication |
| 127447412 | 12744741 | 5 | Product used for unknown indication |
| 127447412 | 12744741 | 6 | Product used for unknown indication |
| 127447412 | 12744741 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127447412 | 12744741 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127447412 | 12744741 | Encephalopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127447412 | 12744741 | 1 | 20140318 | 20140318 | 0 | |
| 127447412 | 12744741 | 2 | 20140318 | 20140319 | 0 | |
| 127447412 | 12744741 | 3 | 20140318 | 0 |